Hoyoung Huh, M.D., Ph.D. 13D and 13G filings for Akari Therapeutics, Plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-04 4:44 pm Purchase | 2026-03-02 | 13G | AKARI THERAPEUTICS PLC SPONSOR AKTX | Hoyoung Huh, M.D., Ph.D. | 454,992,442 18.400% | 247,629,742 (+119.42%) | Filing |
| 2025-02-14 5:00 pm Purchase | 2024-11-14 | 13G | AKARI THERAPEUTICS PLC SPONSOR AKTX | Hoyoung Huh, M.D., Ph.D. | 207,362,700 15.500% | 207,362,700 (New Position) | Filing |